Dr. Gymbro
←

#insulin resistance

1 article
A clean, modern editorial flat-lay on a pale oat-colored linen surface, shot from slightly above in soft diffused natural window light. At the center sits an amber glass supplement bottle with a minimalist cream label, unbranded, with a few capsules spilling onto the fabric in soft greens and ivory tones. Around it are fresh botanical elements: a sprig of green tea leaves, sliced ginger root, a small bundle of dried hibiscus petals, and a few pale green pineapple and papaya slices hinting at digestive enzymes. A small ceramic bowl of creamy plain yogurt with a wooden spoon suggests probiotics. To the left, a flexible tailor's measuring tape in soft blush pink loosely curls across the linen, with a slim brushed-brass scale partly visible at the frame edge. On the right, a minimalist white notebook lies open with a hand-drawn simple line chart showing two diverging lines, one trending downward and one flat, with no readable text. A pair of reading glasses with thin gold frames rests beside it, and a tiny pair of balanced brass scales sits in the background, subtly suggesting weighing evidence and caution.

The palette is muted sage green, warm cream, soft terracotta, and touches of blush and brass. Shadows are gentle and long, the depth of field is shallow with a creamy blurred background, and the negative space on the left third of the frame leaves room for a headline overlay. The overall feel is a contemporary health and science journal, calm, trustworthy, and slightly skeptical, in the style of a premium wellness magazine photographed with a 50mm lens, with crisp texture on linen, glass, and botanicals.
nutrition

SlimSEB: Mezcla probiótica‑enzimática supera al placebo, pero hay una trampa

BY DR. GYMBRO ·

Una combinación de probióticos, enzimas y extractos botánicos llamada SlimSEB superó al placebo en un ensayo aleatorizado de 12 semanas con 87 adultos con riesgo de diabetes tipo 2. Los participantes obesos perdieron 4,5 kg más que el grupo placebo y redujeron su cintura 11 cm, mientras que los niveles de colesterol y la resistencia a la insulina también mejoraron. Sin embargo, el producto fue suministrado por su fabricante, el estudio fue pequeño y de corta duración, y la fórmula multicomponente impide atribuir el efecto a un solo ingrediente. A continuación se analizan los datos, se comparan con los fármacos GLP‑1 y se indica a quién conviene ser cauteloso.

This page is available in